{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:07Z","timestamp":1761178447401,"version":"build-2065373602"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.canrad.2014.12.005","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T04:32:46Z","timestamp":1426134766000},"page":"127-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Place de l\u2019arcth\u00e9rapie modul\u00e9e et de la chimioth\u00e9rapie concomitante dans la prise en charge des cancers du canal anal localement \u00e9volu\u00e9s"],"prefix":"10.1016","volume":"19","author":[{"given":"I.","family":"Troussier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Servagi-Vernat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Benahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ortholan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dejean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fenoglietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vieillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.-J.","family":"Bensadoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2014.12.005_bib0005","series-title":"WHO classification of tumours of the digestive system","first-page":"185","article-title":"Tumours of the anal canal","author":"Welton","year":"2010"},{"key":"10.1016\/j.canrad.2014.12.005_bib0010","first-page":"269","article-title":"Anatomie pathologique des cancers du canal anal","volume":"3","author":"Fl\u00e9jou","year":"2011","journal-title":"Cancero Digest"},{"key":"10.1016\/j.canrad.2014.12.005_bib0015","first-page":"130","article-title":"Le cancer \u00e9pidermo\u00efde du canal anal dans le d\u00e9partement de la C\u00f4te d\u2019Or","volume":"15","author":"Bedenne","year":"1989","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0020","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1200\/JCO.2012.44.5486","article-title":"Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the French hospital database on HIV","volume":"30","author":"Piketty","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0025","first-page":"194","article-title":"On the etiology of anal squamous carcinoma","volume":"49","author":"Frisch","year":"2002","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.canrad.2014.12.005_bib0030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.25671","article-title":"Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study","volume":"129","author":"Abramowitz","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0035","first-page":"1165","article-title":"Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"40","author":"Glynne-Jones","year":"2014","journal-title":"Radiother Oncol"},{"year":"2009","series-title":"International Union Against Cancer (UICC). TNM classification of malignant tumours","author":"Sobin","key":"10.1016\/j.canrad.2014.12.005_bib0040"},{"year":"2010","series-title":"American Joint Committee on Cancer Clinical staging manual","author":"Edge","key":"10.1016\/j.canrad.2014.12.005_bib0045"},{"key":"10.1016\/j.canrad.2014.12.005_bib0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0016-5107(94)70207-1","article-title":"Endoscopic ultrasonography in the staging and follow-up of epidermoid carcinoma of the anal canal","volume":"40","author":"Roseau","year":"1994","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.canrad.2014.12.005_bib0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-1999-35","article-title":"Endoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas","volume":"31","author":"Magdeburg","year":"1999","journal-title":"Endoscopy"},{"key":"10.1016\/j.canrad.2014.12.005_bib0060","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.dld.2014.01.004","article-title":"Results of age-dependent anal canal cancer treatment: a single centre retrospective study","volume":"46","author":"Claren","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.canrad.2014.12.005_bib0065","series-title":"Th\u00e9saurus national de canc\u00e9rologie digestive (TNCF)\u00a9","article-title":"Chapitre 6. Cancer du canal anal","author":"Deutsch","year":"2010"},{"key":"10.1016\/j.canrad.2014.12.005_bib0070","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2006.12.052","article-title":"Predictors and patterns of recurrence after definitive chemoradiation for anal cancer","volume":"68","author":"Das","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0075","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","article-title":"Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning","volume":"78","author":"Wright","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0080","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/1097-0142(19841115)54:10<2062::AID-CNCR2820541004>3.0.CO;2-T","article-title":"Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy","volume":"54","author":"Cummings","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0085","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/1097-0142(19830515)51:10<1830::AID-CNCR2820511013>3.0.CO;2-Z","article-title":"A new approach to the management of epidermoid carcinoma of the anal canal","volume":"51","author":"Papillon","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-8140(85)80019-0","article-title":"Squamous cell carcinoma of the anal canal: treatment by external beam irradiation","volume":"3","author":"Eschw\u00e8ge","year":"1985","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0095","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/1097-0142(19940315)73:6<1569::AID-CNCR2820730607>3.0.CO;2-F","article-title":"Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270\u00a0patients","volume":"73","author":"Touboul","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0100","first-page":"911","article-title":"Cancer du canal anal\u00a0: r\u00e9sultats du traitement d\u2019une s\u00e9rie de 195\u00a0cas","volume":"9","author":"Salmon","year":"1985","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0105","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomized UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0110","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0115","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0120","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11\u00a0phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0125","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, openlabel, 2\u00d72\u00a0factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0130","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03\u00a0trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0135","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1200\/jco.2009.27.15_suppl.4033","article-title":"Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): definitive analysis of the intergroup ACCORD 03\u00a0trial","volume":"27","author":"Conroy","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0140","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.canrad.2014.12.005_bib0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2007.12.027","article-title":"Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08","volume":"72","author":"Konski","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0150","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","article-title":"The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomittant chemotherapy","volume":"50","author":"Weber","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0155","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2329::AID-CNCR6>3.0.CO;2-G","article-title":"The impact of treatment factors on local control in T2-T3\u00a0anal carcinomas treated by radiotherapy with or without chemotherapy","volume":"15","author":"Allal","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0360-3016(03)00417-6","article-title":"Results of definitive irradiation in a series of 305\u00a0epidermoid carcinomas of the anal canal","volume":"56","author":"Deniaud-Alexandre","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-8140(00)00213-9","article-title":"Proliferation parameters in epidermoid carcinomas of the anal canal","volume":"56","author":"Wong","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0170","first-page":"109","article-title":"Les nouveaux \u00e9quipements en radioth\u00e9rapie","volume":"94","author":"Mazeron","year":"2007","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0175","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10269-007-0653-x","article-title":"Radioth\u00e9rapie par modulation d\u2019intensit\u00e9","volume":"9","author":"Maingon","year":"2007","journal-title":"Oncologie"},{"key":"10.1016\/j.canrad.2014.12.005_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jicru_ndq002","article-title":"ICRU report 83: prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT)","volume":"10","author":"ICRU","year":"2010","journal-title":"J ICRU"},{"key":"10.1016\/j.canrad.2014.12.005_bib0185","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1278-3218(00)00019-6","article-title":"\u00c9tude comparative dosim\u00e9trique de deux m\u00e9thodes de modulation d\u2019intensit\u00e9 r\u00e9alis\u00e9es sur le m\u00eame acc\u00e9l\u00e9rateur","volume":"4","author":"Marchesi","year":"2000","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.12.005_bib0190","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1684\/bdc.2010.1135","article-title":"Tomoth\u00e9rapie h\u00e9lico\u00efdale\u00a0: aspects techniques et applications cliniques","volume":"97","author":"Dejean","year":"2010","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.canrad.2014.12.005_bib0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1118\/1.2818738","article-title":"Volumetric modulated arc therapy: IMRT in a single gantry arc","volume":"35","author":"Otto","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0200","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1684\/bdc.2010.1150","article-title":"Technologie RapidArc\u00ae\u00a0: premi\u00e8re ann\u00e9e d\u2019exp\u00e9rience au CRLC Val-d\u2019Aurelle de Montpellier","volume":"97","author":"Fenoglietto","year":"2010","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.canrad.2014.12.005_bib0205","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.canrad.2011.05.011","article-title":"De la radioth\u00e9rapie guid\u00e9e par l\u2019image \u00e0 la radioth\u00e9rapie guid\u00e9e par la dose","volume":"15","author":"Cazoulat","year":"2011","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.12.005_bib0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.canrad.2009.06.018","article-title":"Radioth\u00e9rapie guid\u00e9e par la tomographie conique (cone beam computed tomography)\u00a0: mise en \u0153uvre et applications cliniques","volume":"13","author":"De Crevoisier","year":"2009","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.12.005_bib0215","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1684\/bdc.2010.1140","article-title":"La radioth\u00e9rapie guid\u00e9e par l\u2019image (IGRT)","volume":"97","author":"Lagrange","year":"2010","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2014.12.005_bib0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","article-title":"Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome","volume":"63","author":"Milano","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0225","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijrobp.2005.05.052","article-title":"Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal\/femoral nodes","volume":"63","author":"Chen","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-2-41","article-title":"Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans","volume":"2","author":"Menkarios","year":"2007","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2\u00a0evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0240","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1748-717X-7-45","article-title":"IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center","volume":"7","author":"Vieillot","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1748-717X-7-201","article-title":"Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?","volume":"7","author":"Dewas","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0255","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","article-title":"Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy","volume":"82","author":"Kachnic","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0260","first-page":"39","article-title":"Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal","volume":"6","author":"Chuong","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.canrad.2014.12.005_bib0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1748-717X-5-10","article-title":"FDG-PET\/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma","volume":"5","author":"Krengli","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0270","first-page":"280","article-title":"Radiation therapy of anal canal carcinoma","volume":"3","author":"de la Rochefordi\u00e8re","year":"2011","journal-title":"Cancero Digest"},{"key":"10.1016\/j.canrad.2014.12.005_bib0275","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0280","series-title":"Site Internet de radioanatomie et d\u2019autoenseignement \u00e0 la delineation (Siriade)","article-title":"RCMI canal anal","author":"Azria","year":"2011"},{"key":"10.1016\/j.canrad.2014.12.005_bib0285","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat OncolBiol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-717X-5-92","article-title":"Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer","volume":"5","author":"Vieillot","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.canrad.2013.12.008","article-title":"Apport de la RCMI rotationnelle et de la tomoth\u00e9rapie h\u00e9lico\u00efdale dans les cancers pelviens\u00a0: \u00e9tude dosim\u00e9trique prospective sur 51\u00a0patients","volume":"18","author":"Servagi-Vernat","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.12.005_bib0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.canrad.2010.06.012","article-title":"Quelle RCMI\u00a0? Du \u00ab\u00a0step and shoot\u00a0\u00bb au VMAT\u00a0: point de vue du physicien","volume":"14","author":"Lafond","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.12.005_bib0305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.canrad.2004.10.006","article-title":"Recommandations pour un protocole d\u2019assurance de qualit\u00e9 de la radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 des cancers de la t\u00eate et du cou","volume":"8","author":"Zefkili","year":"2004","journal-title":"Cancer Radiother"},{"year":"2010","series-title":"Contr\u00f4les de qualit\u00e9 en radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9 [rapport SFPM no 26]","author":"Valinta","key":"10.1016\/j.canrad.2014.12.005_bib0310"},{"year":"2008","series-title":"Recommandations relatives \u00e0 la recette des dispositifs m\u00e9dicaux de radioth\u00e9rapie externe","author":"Anon.","key":"10.1016\/j.canrad.2014.12.005_bib0315"},{"key":"10.1016\/j.canrad.2014.12.005_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.icrp.2009.12.001","article-title":"Preventing accidental exposures from new external beam radiation therapy technologies [ICRP Publication 112]","volume":"39","author":"Ortiz Lopez","year":"2009","journal-title":"Ann ICRP"},{"year":"2008","series-title":"Guidelines for the verification of IMRT","author":"Alber","key":"10.1016\/j.canrad.2014.12.005_bib0325"},{"key":"10.1016\/j.canrad.2014.12.005_bib0330","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1118\/1.1591194","article-title":"Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee","volume":"30","author":"Ezzell","year":"2003","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0335","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.ijrobp.2003.12.008","article-title":"Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine","volume":"58","author":"Galvin","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0340","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2008.08.055","article-title":"Commissioning of volumetric modulated arc therapy (VMAT)","volume":"73","author":"Bedford","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0345","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1118\/1.3089793","article-title":"A comprehensive analysis of the IMRT dose delivery process using statistical process control (SPC)","volume":"36","author":"G\u00e9rard","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0350","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1118\/1.2001209","article-title":"Statistical process control for radiotherapy quality assurance","volume":"32","author":"Pawlicki","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.canrad.2014.12.005_bib0355","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canrad.2010.03.002","article-title":"Ma\u00eetrise statistique des processus appliqu\u00e9e aux contr\u00f4les avant traitement par dosim\u00e9trie portale en radioth\u00e9rapie conformationnelle avec modulation d\u2019intensit\u00e9","volume":"14","author":"Villani","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2014.12.005_bib0360","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2008.12.016","article-title":"Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review","volume":"91","author":"Tubiana","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0365","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00066-013-0314-5","article-title":"Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature","volume":"189","author":"Fakhrian K1","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0370","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","article-title":"Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128\u00a0survivors","volume":"52","author":"Bentzen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2014.12.005_bib0375","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.canrad.2013.06.032","article-title":"Recommandations pour la d\u00e9lin\u00e9ation des aires ganglionnaires pelviennes dans le cancer du canal anal","volume":"17","author":"Vendrely","year":"2013","journal-title":"Cancer Radiother"},{"year":"2014","series-title":"NCCN clinical practice guidelines (NCCN Guidelines\u00ae) in oncology. Anal carcinoma","author":"Anon.","key":"10.1016\/j.canrad.2014.12.005_bib0380"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321815000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:23:08Z","timestamp":1761135788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321815000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1278321815000128"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2014.12.005","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Place de l\u2019arcth\u00e9rapie modul\u00e9e et de la chimioth\u00e9rapie concomitante dans la prise en charge des cancers du canal anal localement \u00e9volu\u00e9s","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2014.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}